CompletedNot applicableNCT06202560
Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study
Studying Frontal fibrosing alopecia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Institute of Dermatology, Thailand
- Principal Investigator
- Chinmanat Lekhavat, MDInstitute of Dermatology
- Intervention
- Tofacitinib 5 MG(drug)
- Enrollment
- 11 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2024
Study locations (1)
- Hair and Nail center, Institute of Dermatology, Bangkok, Thailand
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06202560 on ClinicalTrials.gov